The chemistry, pharmacology and clinical properties of Sambucus ebulus: A review

Journal of Medicinal Plants Research

Volumn 4, Issue 2, 2010, Pages 095-103

  Shokrzadeh, M ^a   Saeedi Saravi, S S ^a  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adoxaceae; Anti cancer; Anti inflammatory; Anti nociceptive; Anti oxidative; RIPS; Sambucus ebulus

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTINOCICEPTIVE AGENT; ANTIOXIDANT; ATHOCYANIN; EBULIN 1; EBULITIN; EBULOSID; FLAVONOID; PLACEBO; PLANT EXTRACT; SAMBUCUS EBULUS EXTRACT; SAMBUNIGRIN; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTINOCICEPTION; ANTIOXIDANT ACTIVITY; ASCITES; BIOLOGICAL ACTIVITY; BITE; CHEMISTRY; CLINICAL TRIAL; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG STRUCTURE; HELICOBACTER INFECTION; HEMORRHOID; HUMAN; INFLAMMATION; INFLUENZA; MEDICINAL PLANT; NONHUMAN; REVIEW; SAMBUCUS; SAMBUCUS EBULUS; SORE THROAT; TRADITIONAL MEDICINE;

ADOXACEAE; SAMBUCUS EBULUS;

EID: 76149140477     PISSN: 19960875     EISSN: 19960875     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Aruoma OI (2003). Methodological considerations for characterizing potential antioxidant actions of bioactive components in plant foods. Mutat. Res. 523-524: 9-20.
2. Azadbakht M (1999). Classification of medical plants. Teimoorzadeh press, Tehran, Iran.
3. Barbieri L, Battelli MG, Stirpe F (1993). Ribosome-inactivating proteins from plants. Biochim. Biophys. Acta. 1154: 237-282.
4. Benitez J, Ferreras JM, Munoz R, Arias Y, Iglesia R, Cordoba-Diaz M, Villar R, Girbes T (2005). Cytotoxicity of an Ebulin l-Anti-Human CD105 Immunotoxin on Mouse Fibroblasts (L929) and Rat Myoblasts (L6E9) Cells Expressing Human CD105. Med. Chem. 1(1): 65-71.
5. Bonita JS, Mandarano M, Shuta D, Vinson J (2007). Coffee and cardiovascular disease: in vitro, cellular, animal, and human studies. Pharmacol. Res. 55: 187-198.
6. Bouayed J, Rammal H, Dicko A, Younos C, Soulimani R (2007). Chlorogenic acid, a polyphenol from Prunus domestica (Mirabelle), with coupled.
7. Buhrmester RA, Ebinger JE, Seigler DS (2000). Sambunigrin and cyanogenic variability in populations of Sambucus Canadensis L. (Caprifoliaceae). Biochem. Sys. Ecol. 28: 689-695.
8. Campa, C. Schmitt-Kopplin Ph, Cataldi TRI, Bufo SA, Freitag D, Kettrup A (2000): Analysis of cyanogenic glycosides by micellar capillary electrophoresis. J. Chromatogr. B. Biomed. Sci. Appl. 739(1): 95-100.
9. Charles A, Dinarello MD (2000). Proinflammatory cytokines. CHEST 118: 503-508.
10. Cho JY, Park SC, Kim TW, Kim KS, Song JC, Kim SK, Lee HM, Sung HJ, Park HJ, Song YB, Yoo ES, Lee CH, Rhee MH (2006). Radical scavenging and anti-inflammatory activity of extracts from Opuntia humifusa Raf. J. Pharm. Pharmacol. 58: 113-119.-
11. Ahmadiani A, Fereidoni M, Semnanian S, Kamalinejad M, Saremi S (1998). Antinociceptive and anti-inflammatory effects of Sambucus ebulus rhizome Extract in rats. J. Ethnopharmacol. 61: 229-235.
12. Citores L, Ferreras JM, Iglesias R, Carbajales ML, Arias FJ, Jim6nez P, Rojo MA, Girbes T (1993). FEBS. Lett. 329: 59-62.
13. Davis PH (1965-1988). Flora of Turkey and the east Aegean islands. (F Turk)
14. De Benito FM, Citores L, Iglesias R, Ferreras JM, Soriano F (1995). Ebulitins: A new family of type 1 ribosome-inactivating proteins (rRNA N-glycosidases) from leaves of Sambucus ebulus L. that coexist with the type 2 ribosome-inactivating protein ebulin 1. FEBS Lett. 360(3): 299-302.
15. Duke JA, Vinson J, Lord JM (2002). CRC Handbook of medicinal herbs. (CRC MedHerbs ed2).
16. Ebrahimzadeh MA, Ehsanifar S, Eslami B (2009a). Sambucus ebulus elburensis fruits: A good source for antioxidants. Phcog. Mag. 4(19): 213-218.
17. Ebrahimzadeh MA, Nabavi SF and Nabavi SM (2009b). Antioxidant Activities of Methanol Extract of Sambucus ebulus L. Flower. Pakistan. J. Biol. Sci. 12(5): 447-450.
18. Ebrahimzadeh MA, Mahmoudi M, Karami M, Saeedi Saravi SS, Ahmadi AH, Salimi E (2007). Separation of Active and Toxic Poisons in Sambucus ebulus. Pakistan. J. Biol. Sci. 10(22): 4171-3.
19. Ebrahimzadeh MA, Mahmoudi M, Pourmorad F, Saeidnia S, Salimi E (2006). Anti-inflammatory and anti-nociceptive properties of fractionated extracts in different parts of Sambucus ebulus. J. Mazandaran. Uni. Med. Sci. 16(54): 35-42.
20. Elisabetsky E, Amador TA, Albuquerque RR, Nunes DS, Carvalho ACT (1995). Analgesic activity of Psychotria colorata Muell. Arg. Alkaloids. J. Ethnopharmacol. 48: 77-83.
21. Endo Y, Tsurugi K (1987). RNA N-glycosidase activity of ricin A-chain. Mechanism of action of the toxic lectin ricin on eukaryotic ribosomes. J. Biol. Chem. 262(17): 8128-8130.
22. Fabry W, Okemo P, Mwatha WE, Chauder S, Ansorg R (1996). Susceptibility of Helicobacter pylori and Candida spp. to the East African Plant Terminalia spinosa. Arzneimittel -Forschung: Drug Res. 46: 539-541.
23. Folkman J (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med.1: 27-31.
24. Fonsatti E, Altomonte M, Arslan P, Maio M (2003). A target for anti-angiogenetic cancer therapy. Curr. Drug Targets 4(4): 291-296.
25. Ghannadi AR, Ghassemi-Dehkordi N (1997). Pharmacognostical Investigations on Sambucus ebulus L. and Sambucus nigra L. Daru. 7(1): 55.
26. Girbes T, Ferreras JM, Arias FJ, Muñoz R, Iglesias R, Jiménez P, Rojo MA, Arias Y, Pérez Y, Benítez J, Sánchez D, Gayoso MJ (2003). Non-toxic type 2 ribosome-inactivating proteins (RIPs) from Sambucus: occurrence, cellular and molecular activities and potential uses. Cell. Mol. Biol. 49(4): 537-545.
27. Girbes T, Citores L, Iglesias R, Ferreras JM, Munoz R, Rojo MA, Arias FJ, Garcia JR, Mendez E, Calonge M (1993). Ebulin 1, a nontoxic novel type 2 ribosome-inactivating protein from Sambucus ebulus L. leaves. J. Biol. Chem. 268(24): 18195-18199.
28. Gordon MH (1990). The Mechanism of Antioxidant Action in vitro. In: Food Antioxidants. Hudson BJF (Ed.). Elsevier Applied Science, London, UK, pp. 1-18.
29. Gross GA, Sticher O, Anklin C (2004). A Novel Ester Iridoid Glucoside from Sambucus ebulus L. (Caprifoliaceae). Helvetica. Chimica. Acta. 69(1): 156-162.
30. Guarrera PM (1999). Traditional antihelmintic, antiparasitic and repellent uses of plants in Central Italy. J. Ethnopharmacol. 68(1-3): 183-192.
31. Hanahan D, Folkman J (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86: 353-364.
32. Halliwell B, Gutteridge JMC (1990). Role of free radicals and catalytic metal ions in human disease: An overview. Method Enzymol. 186: 1-85.
33. Hartley MR, Legname G, Osborn R, Chen Z, Lord JM (1991). Single-chain ribosome inactivating proteins from plants depurinate Escherichia coli 23S ribosomal RNA. FEBS Lett. 290: 65-68.
34. Hebbel RP, Leung A, Mohandas N (1990). Oxidation-induced changes in microheological properties of the red cell membrane. Blood 76: 1015-1020.
35. Hogg N (1998). Free radicals in disease. Seminars in reproductive endocrinology 16: 241-248.
36. Howard M (1987). Traditional Folk Remedies. Century pp. 134-5
37. Huang CH, Kingston DG, Magri NF, Samaranayake G, Boettner FE (1986). New taxanes from Taxus brevifolia. . Nat. Pro. 49(4): 665-669.
38. Hyun TK, Kim JS (2009). The pharmacology and clinical properties of Kalopanax pictus. J. Med. Plants Res. 3(9): 613-620.
39. Imamura L, Tsuchiya M, Inada A, Nakanishi T, Kobayashi K (1995). Inhibition of urease and growth of Helicobacter pylori by herb extracts. J. Tradit. Med. 12: 129-136.
40. Jafarian-Dehkordi A, Emami SA, Saeidi M, Sadeghi H (2004). Cytotoxicologic Studies of the Extracts of Iranian Juniperus Sabina and Platycladus orientalis on Cancer Cells. J. Res. Med. Sci. 5: 205-209.
41. Jain RK (1990). Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev. 9: 253-266.
42. Jensen SR, Nielsen BJ (1973). Cyanogenic glucosides in Sambucus nigra L. Acta. Chem. Scand. 27: 2661-2662.
43. Korman MG, Bolin TD, Engelmann JI, Pianko S (1997). Sucralfate as an alternative to bismuth in quadruple therapy for Helicobacter pylori eradication. Helicobacter. 2: 140-143.
44. Kreitman RJ (2000). Immunotoxins. Exp. Opin. Pharmacother. 1: 1117-1129.
45. Lundberg IE (2003). Clinical symptoms in patients with myositis-an acquired metabolic myopathy? Idiopathic inflammatory myopathies: why do the muscles become weak? Curr. Opin. Rheumatol. 15: 675-678.
46. Maio M, Altomonte M, Calabrio L, Fonsatti E (2001). Bioimmunotherapeutic targets on angiogenetic blood vessels in solid malignangies. Frontiers Biosci. 6: d776-784.
47. Mates JM, Perez-Gomez C, Nunez de Castro I (1999). Antioxidant enzymes and human diseases. Clin. Biochem. 32: 595-603.
48. Matsuno F, Haruta Y, Kondo M, Tsai H, Barcos M, Seon BK (1999). Induction of Lasting Complete Regression of Preformed Distinct Solid Tumors by Targeting the Tumor Vasculature Using Two New Anti Endoglin Monoclonal Antibodies. Clin. Cancer Res. 5(2): 371-382.
49. Medina I, Gallardo JM, Gonzalez MJ, Lois S, Hedges N (2007). Effect of molecular structure of phenolic families as hydroxycinnamic acids and. J. Agric. Food Chem. 55: 3889-3895.
50. Medve R J, Medve ML (1990). Edible Wild Plants of Pennsylvania and Neighboring States. Penn State Press, 161p.
51. Mirhaydar H (1994). Plant Information: Plant Usage in Disease Treatment. Islamic Farhang Press, Tehran pp. 303-304.
52. Nabavi SM, Ebrahimzadeh MA, Nabavi SF, Jafari M (2008a). Free radical scavenging activity and antioxidant capacity of Eryngium caucasicum Trautv and Froripia subpinata. Pharmacologyonline. 3: 19-25.
53. Nabavi, SM, Ebrahimzadeh MA, Nabavi SF, Hamidinia A, Bekhradnia AR (2008b). Determination of antioxidant activity, phenol and flavonoid content of Parrotia persica MEY. Pharmacol. Online. 2: 560-567.
54. Nova Scotia Museum Website, Poison plant section, Nova Scotia Museum - Poisonous plants- Westwood J (1985). Albion. A Guide to Legendary Britain. Grafton Books, London 103p.
55. Novak K (2002). Angiogenesis inhibitors revised and revived at AACR. Nat. Med. 8: 427.
56. Ognyanov I, Popov A, Ivanova B, Dinkov D, Petkov V (1979). Sambucus ebulus Linnaeus, phytochemical and pharmacological screening. Rivista Italiana Essenze, Profumi, Piante Officinali, Aromi, Saponi, Cosmetici Aerosol. 61: 114-118.
57. Olsnes S, Pihl A (1982). In: Cohen P and Van Heyningen S, Editors, Molecular Action of Toxins and Viruses, Elsevier, New York, pp. 51-105.
58. Petkov V (1986) A source of ideas for phytopharmacological investigations. J. Ethnopharmacol. 15: 121-132.
59. Prasain JK, Stefanowicz P, Kiyota T, Habeichi F, Konishi Y (2001). Taxines from the needles of Taxus wallichiana. Phytochemistry 58(8): 1167-1170.
60. Pribela A, Durcanska J, Piry J, Karovicova J (1992). Volatile substances of dwarf elder Sambucus ebulus L. fruits. Biologia. (Bratislava) 47(3): 225-230.
61. Rechinger KH (1963). Flora iranica. (F Iran)
62. Reznichenko L, Amit T, Zheng H, Avramovich-Tirosh Y, Youdim MBH, Weinreb O, Mandel S (2006). Reduction of iron-regulated amyloid precursor protein and [beta]-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: Implications for iron chelation in Alzheimer's disease. J. Neurochem. 97: 527-536.
63. Rhee MH, Park HJ, Cho JY (2009). Salicornia herbacea: Botanical, chemical and pharmacological review of halophyte marsh plant. J. Med. Plants Res. 3(8): 548-555.
64. Saeedi Saravi SS, Shokrzadeh M (2009a). Anti-inflammatory, toxic effects, biochemical and pathological analysis in presence or lack of vitamins C and E, and cytotoxicity of n-hexane, methanolic and ethyl acetate extracts of Sambucus ebulus. Toxicol. Lett. 189S: S166-167.
65. Saeedi Saravi SS, Shokrzadeh M (2009b). Histopathological and Biochemical Disorders Following Administration of Sambucus ebulus Extract on Mice & Rats and Preventive Effects of Vitamins C and E on Renal & Hepatic Disorders. Phcog. Mag. 5(19 [Suppl]): 131-135.
66. Saeedi Saravi SS, Shokrzadeh M (2008). The study of hepatic and renal disorders in mice which were administered ethyl acetate extract of plant Sambucus ebulus intraperitoneally (IP) and effect of vitamins C and E on prevention of its disorders. Toxicol. Lett. 180S: S57-58.
67. Seon BK, Matsuno F, Haruta Y, Kondo M, Barcos M (1997). Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin. Clin. Cancer Res. 3(7): 1031-1044.
68. Sharma SK, Ali M, Gupta J (2002). Hepatoprotective activity of aqueous ethanolic extract of Chamomile capitula in paracetamol intoxicated albino rats. Phytochem. Pharmacol. 2: 253-270.
69. Shokrzadeh M, Saeedi Saravi SS, Mirzayi M (2009). Cytotoxic Effects of Ethyl Acetate Extract of Sambucus ebulus Compared With Etoposide on Normal and Cancer Cell Lines. Phcog. Mag. 5(20): 316-319.
70. Stirpe F, Bailey S, Miller SP, Bodley JW (1988). Modification of ribosomal RNA by ribosome-inactivating proteins from plants. Nucl. Acids Res. 16(4):1349-1357.
71. Thorpe PE, Burrows FJ (1995). Antibody-directed targeting of the vasculature of solid tumors. Breast Cancer Res. Treat. 36(2): 237-251.
72. Tutin TG et al. (1964-1980). Flora europaea. (F Eur)
73. Tuzlaci E, Tolon E (2000). Turkish folk medicinal plants, part III: Sile (Istanbul). Fitoterapia 71: 673-685.
74. Vane JR, Botting RM (2003). The mechanism of action of aspirin. Thromb. Res. 110: 255-258.
75. Van Uden W, Homan B, Woerdenbag HJ, Pras N, Malingre TM, Wichers HJ, Harkes M (1992). Isolation, purification, and cytotoxicity of 5-methoxypodophyllotoxin, a lignan from a root culture of Linum flavum. J. Nat. Pro. 55(1): 102-110.
76. Vernon H (1987). Flowering Plants of the World. Andromeda Oxford Ltd, Heywood.
77. Von Mehren M, Adams GP, Weiner LM (2003). Monoclonal antibody therapy for cancer. Annu. Rev. Med. 54: 343-369.
78. Walsh LJ (2003). Mast cells and oral inflammation. Crit. Rev. Oral Biol. Med. 14: 188-198.
79. Wiseman SA, Balentine DA, Frei B (1997). Antioxidants in tea. Crit. Rev. Food. Sci. Nutr. 37: 705-718.
80. Yesilada E, Gurbuz I, Shibata H (1999). Screening of Turkish anti-ulcerogenic folk remedies for anti-Helicobacter pylori activity. J. Ethnopharmacol. 66: 289-293.
81. Samsamshariat H, Moattar F, Afsharypour S (1981). Treatment with Plants. Marshal Press, Tehran, pp. 61-253.
82. Yesilada E (1995). Evaluation of the anti-inflammatory activity of the Turkish medicinal plant Sambucus ebulus. Chem. Nat. Comp. 33(5): 539-540.
83. Zakay-Rones Z, Varsano N, Zlotnik M, Manor O, Regev L, Schlesinger M, Mumcuoglu M (1995). Inhibition of Several Strains of Influenza Virus in Vitro and Reduction of Symptoms by an Elderberry Extract (Sambucus nigra L.) during an Outbreak of Influenza B Panama. J. Altern. Complement. Med. 1 (4): 361-369.
84. Zakay-Rones Z, Thom E, Wollan T, Wadstein J (2004). Randomized Study of the Efficacy and Safety of Oral Elderberry Extract in the Treatment of Influenza A and B Virus Infections. J. Int. Med. Res. 32(2):132-140.
85. Zargari A (1981). Medicinal plants. Tehran University Press, Iran, pp. 5-10.